“…The derivation of podocytes from pluripotent stem cells is an attractive alternative and an inexhaustible source of podocytes. Recently, different protocols for iPSC commitment towards renal progenitor cells through the activation of Wnt, bone morphogenic protein (BMP), fibroblast growth factor (FGF) and retinoic acid (RA) pathways involved in the induction of the intermediate mesoderm (IM) and subsequently in the metanephric mesenchyme and ureteric bud cells have been reported (Batchelder et al, 2009, Imberti et al, 2015, Kim and Dressler, 2005, Mae et al, 2010, Mae et al, 2013, Oeda et al, 2013, Taguchi et al, 2014, Takasato et al, 2014, Xia et al, 2013). The feasibility of deriving more mature kidney cells from pluripotent stem cells has also been demonstrated (Kang and Han, 2014, Kobayashi et al, 2005, Lam et al, 2014, Song et al, 2012).…”